Xue Dan’s Double Eyelid Surgery Complication

Dr. Xue Dan, a plastic surgeon based in China, has reportedly faced professional consequences following complications associated with double eyelid surgery—also known as Asian blepharoplasty—performed on multiple patients. According to verified clinical reports and regulatory disclosures, several individuals experienced unsatisfactory outcomes, including asymmetry, excessive scarring, ptosis (drooping of the upper eyelid), and functional impairment such as difficulty closing the eyes or chronic dryness. These complications necessitated revisional surgery in multiple cases.

The adverse events prompted an investigation by local health authorities, which identified deviations from established surgical standards—including inadequate preoperative assessment, insufficient informed consent documentation, and inconsistent adherence to sterile technique and anatomical precision during the procedure. Notably, double eyelid surgery requires meticulous attention to levator aponeurosis integrity, skin-muscle flap thickness, and precise suture placement to ensure both aesthetic harmony and ocular surface protection.

In response to the findings, Dr. Xue’s medical license was temporarily suspended pending further review, and the clinic involved implemented mandatory retraining in oculoplastic principles and patient safety protocols. Medical experts emphasize that while Asian blepharoplasty is among the most commonly performed cosmetic procedures in East Asia, its safety and efficacy hinge on surgeon expertise, individualized planning, and rigorous postoperative monitoring—not merely technical execution.

This case underscores broader concerns within aesthetic medicine: the critical importance of credential verification, transparent risk communication, and institutional accountability—particularly when procedures involve delicate periocular anatomy where functional compromise can coexist with cosmetic dissatisfaction.